SEACare 2024 comes to a successful conclusion
On April 19, the 24th Malaysia Medical Devices & Rehabilitation Healthcare Exhibition 2024 was successfully held at the Kuala Lumpur Convention Centre. At the 3-day exhibition, Wizbiotech brought "fast, accurate and stable" detection reagents, detection instruments and advanced POCT grass-roots solutions to show the strength of China's in vitro diagnosis industry, which received attention and praise from participants.
After 10 years of professional precipitation, we have the strength, hope and confidence to win the market with excellent products and services and leading POCT system solutions. The POCT grass-roots solution exhibited by Wizbiotech at the exhibition combines rapid detection technology and portable devices to enable rapid and accurate diagnosis in primary medical institutions, greatly reducing the waiting time and diagnostic cycle of patients, keeping patients at the grass-roots level, reducing the burden of large hospitals, and improving the efficiency and quality of primary care.
At the exhibition site, we also focused on promoting gastrointestinal health examination, infectious disease detection, tumor marker detection and other products, providing customers with one-on-one answers and demonstrations to show the characteristics and advantages of the products. At the same time, the Wizbiotech’s team also actively collects customer feedback, summarizes and organizes, and strives to respond to customers as soon as possible to ensure that every customer can receive timely and professional service.
The scene is full of people, in an endless stream, many customers have shown a strong interest in the solutions and products we provide, expressed a high degree of recognition of our technology, and praised our service attitude. This gives us a solid foundation to connect with more customers and partners for future cooperation and development.
Through the successful holding of this exhibition, Wizbiotech has further established its brand image and expanded its market influence. At the same time, the exhibition also provided Wizbiotech with an opportunity to gain an in-depth understanding of the market demand and competition in Malaysia, providing valuable reference and guidance for the company's future development.
In the future, Wizbiotech will continue to improve the product system with POCT as the core, improve product quality and technical level, and constantly meet customer needs. At the same time, the company will also strengthen cooperation with domestic and foreign partners to jointly promote the development of the in vitro diagnosis industry and contribute to the progress of the medical industry.
